Asia-Pacific’s medical devices industry saw a drop of 15.22% in deal activity during July 2022, when compared with the last 12-month average, led by Orbimed Advisors’ $80m venture financing deal with LifeWell, according to GlobalData’s deals database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 39 medical devices industry deals worth $271.4m were announced for the region in July 2022, against the 12-month average of 46 deals.

Of all the deal types, venture financing saw most activity in July 2022 with 36 transactions, representing a 92.3% share for the region.

In second place was M&A with three deals capturing a 7.7% share of the overall deal activity for the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In terms of value of deals, venture financing was the leading category in Asia-Pacific’s medical devices industry with $261.76m, followed by M&A $9.65m.

Asia-Pacific medical devices industry deals in July 2022: Top deals

The top five medical devices deals accounted for 56.9% of the overall value during July 2022.

The combined value of the top five medical devices deals stood at $154.48m, against the overall value of $271.4m recorded for the month.

The top five medical devices industry deals of July 2022 tracked by GlobalData were:

1) Orbimed Advisors $80m venture financing deal with LifeWell

2) The $29.8m venture financing of Beijing Yading Information Technology by Eastern Bell Capital,Haier Capital,Sinovation Ventures and Xingtuo Capital

3) Huatai Zijin Investment,Jointown Pharmaceutical Group,Nanjing New Industry Investment Group and Wenzhou Investment $14.93m venture financing deal with Nanjing Puguang Biotechnology

4) The $14.93m venture financing of Shanghai Keku Medical Technology by Puhua Capital and Qishen Venture Capital

5) Dachen Caizhi,Daoyuan Capital Management (Beijing),Guangzhou Anbiping Pharmaceutical Technology,Huihe Capital,Kaipu Biotechnology and Qiming Venture Partners $14.82m venture financing deal with Beijing Zhizhen Biotechnology